Publication
Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group
Journal Paper/Review - Jan 15, 2003
Rehwald Ute, Engert Andreas, Diehl Volker, Muller-Hermelink Konrad, Rüdiger Thomas, Driessen Christoph, Morschhauser Franck, Staak Jan Oliver, Sieber Markus, Reiser Marcel, Schulz Holger, German Hodgkin Lymphoma Study Group (GHSG)
Rehwald, Ute
2
0
Schulz, Holger
2
0
Reiser, Marcel
2
0
Sieber, Markus
1
0
Staak, Jan Oliver
1
0
Morschhauser, Franck
2
0
Driessen, Christoph
Medizinische Onkologie und Hämatologie · Dept. I
132
29
Rüdiger, Thomas
4
0
Muller-Hermelink, Konrad
2
0
Diehl, Volker
8
0
Engert, Andreas
12
0
German Hodgkin Lymphoma Study Group (GHSG),
1
0